1. Home
  2. Analysis
  3. Pyridium
  4. Pataday

Pyridium and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Pyridium and Pataday together.

The phase IV clinical study analyzes what interactions people who take Pyridium and Pataday have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 27, 2023

5 people who take Pyridium and Pataday together, and have interactions are studied.

What is Pyridium?

Pyridium has active ingredients of phenazopyridine hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 1,628 Pyridium users for its effectiveness, alternative drugs and more.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 7,412 Pataday users for its effectiveness, alternative drugs and more.

Number of Pyridium and Pataday reports submitted per year:

Pyridium and Pataday drug interactions.

Common Pyridium and Pataday drug interactions by gender *:

female:

  1. Chronic left ventricular failure
  2. Dry eye
  3. Nephrogenic anaemia
  4. Renal disorder
  5. Renal failure
  6. Renal injury
  7. Chronic kidney disease

male:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary
  3. Nephrogenic anaemia
  4. Renal failure
  5. Anaemia
  6. Coagulopathy
  7. Gastrooesophageal reflux disease
  8. Haematochezia
  9. Haematuria

Common Pyridium and Pataday drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Chronic kidney disease
  2. Nephrogenic anaemia
  3. Renal failure
  4. Hyperparathyroidism secondary
  5. Anaemia
  6. Coagulopathy
  7. Gastrooesophageal reflux disease
  8. Haematochezia
  9. Haematuria
  10. Renal injury

* Approximation only. Some reports may have incomplete information.

Do you take Pyridium and Pataday?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Pyridium and Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pyridium side effects:

Browse all side effects of Pyridium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pataday side effects:

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pyridium interactions:

Browse all interactions between Pyridium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pataday interactions:

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on phenazopyridine hydrochloride and olopatadine hydrochloride (the active ingredients of Pyridium and Pataday, respectively), and Pyridium and Pataday (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pyridium and Pataday.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.